These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31289060)

  • 1. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; Baars MJH; van Tintelen JP; Smets EMA; Christiaans I
    Eur J Hum Genet; 2022 Feb; 30(2):203-210. PubMed ID: 34815540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.
    Hodgson JM; Metcalfe SA; Aitken M; Donath SM; Gaff CL; Winship IM; Delatycki MB; Skene LL; McClaren BJ; Paul JL; Halliday JL
    BMC Med Genet; 2014 Mar; 15():33. PubMed ID: 24628824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informing relatives at risk of inherited cardiac conditions: experiences and attitudes of healthcare professionals and counselees.
    van den Heuvel LM; Huisinga MJ; Hoedemaekers YM; Baas AF; Plantinga M; Henneman L; van Tintelen JP; Smets EMA; Christiaans I
    Eur J Hum Genet; 2019 Sep; 27(9):1341-1350. PubMed ID: 31053782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
    van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
    J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial.
    Burns C; Yeates L; Semsarian C; Ingles J
    BMJ Open; 2019 Feb; 9(1):e026627. PubMed ID: 30782759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery.
    Shickh S; Hirjikaka D; Clausen M; Kodida R; Mighton C; Reble E; Sam J; Panchal S; Aronson M; Graham T; Armel SR; Glogowski E; Elser C; Eisen A; Carroll JC; Shuman C; Seto E; Baxter NN; Scheer A; Shastri-Estrada S; Feldman G; Thorpe KE; Schrader KA; Lerner-Ellis J; Kim RH; Faghfoury H; Bombard Y
    BMJ Open; 2022 Apr; 12(4):e060899. PubMed ID: 35487723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
    Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.
    Marleen van den Heuvel L; Stemkens D; van Zelst-Stams WAG; Willeboordse F; Christiaans I
    J Genet Couns; 2020 Oct; 29(5):786-799. PubMed ID: 31889383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalising genetic counselling (POETIC) trial: Protocol for a hybrid type II effectiveness-implementation randomised clinical trial of a patient screening tool to improve patient empowerment after cancer genetic counselling.
    Forrest LE; Tutty E; De Silva AP; Petelin L; Ruscigno A; Purvis R; Monohan K; Kentwell M; Sexton A; Stafford L; James PA
    Trials; 2023 Nov; 24(1):712. PubMed ID: 37941026
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Woodard TL; Hoffman AS; Crocker LC; Holman DA; Hoffman DB; Ma J; Bassett RL; Leal VB; Volk RJ
    BMJ Open; 2018 Feb; 8(2):e019994. PubMed ID: 29467138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of physicians and patients towards disclosure of genetic information to spouse and first-degree relatives: a case study from Turkey.
    Akpinar A; Ersoy N
    BMC Med Ethics; 2014 May; 15():39. PubMed ID: 24885495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counselling-based psychosocial intervention to improve the mental health of abused pregnant women: a protocol for randomised controlled feasibility trial in a tertiary hospital in eastern Nepal.
    Sapkota D; Baird K; Saito A; Rijal P; Pokharel R; Anderson D
    BMJ Open; 2019 Apr; 9(4):e027436. PubMed ID: 31015275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.
    Grutters LA; Christiaans I
    Fam Cancer; 2024 Jun; 23(2):155-164. PubMed ID: 38184510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol of a multicenter, single-blind, randomised, parallel controlled feeding trial evaluating the effect of a Chinese Healthy Heart (CHH) diet in lowering blood pressure and other cardiovascular risk factors.
    Xie W; Wang Y; Sun J; Zeng G; Zhu H; Yang Z; Gao P; Yang J; Feng L; Lin PH; Li M; Xu J; Chen J; Wu Y
    BMJ Open; 2020 Aug; 10(8):e036394. PubMed ID: 32819944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of genetic services with and without genetic registers: knowledge, adjustment, and attitudes about genetic counselling among probands referred to three genetic clinics.
    Wright C; Kerzin-Storrar L; Williamson PR; Fryer A; Njindou A; Quarrell O; Donnai D; Craufurd D
    J Med Genet; 2002 Dec; 39(12):e84. PubMed ID: 12471222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.